Inogen (INGN) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuronetics (STIM) has outperformed Inogen (INGN) over the past year, losing 27.9% versus a loss of 32.2%. Over five years, STIM leads with a -56.0% price change compared with -85.7% for INGN. Neuronetics is the larger company by market cap ($163.1 million vs $157.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INGN | STIM |
|---|---|---|
| Share price | $5.94 | $2.14 |
| Market cap | $157.64M | $163.06M |
| 1-day change | +2.06% | -1.38% |
| YTD return | -13.39% | +55.07% |
| 1-year return | -32.25% | -27.95% |
| 5-year return | -85.74% | -55.97% |
| EPS (TTM) | $-0.92 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.13 | $3.44 |
| 52-week low | $5.05 | $0.80 |
| Distance from 52-week high | -34.94% | -37.79% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +102.02% | +168.69% |
| Average volume | 289.77K | 2.08M |
| Shares outstanding | 26.54M | 76.20M |
| Employees | 753 | 658 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Inogen
INGN stock →Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Health Care · Industrial Specialties · 753 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
INGN vs STIM FAQ
Which is bigger, Inogen or Neuronetics?
Neuronetics (STIM) is larger, with a market capitalization of $163.06M compared with $157.64M for Inogen (INGN).
Which stock has performed better over the past year, INGN or STIM?
STIM returned -27.95% over the past 12 months, compared with -32.25% for INGN (price return, excluding dividends). Past performance does not predict future results.
Are Inogen and Neuronetics in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Inogen and Medical/Dental Instruments for Neuronetics.